Shanghai OPM Biosciences Co., Ltd.SSE: 688293

(688293)"SHANGHAI OPM BIOSCIENCES CO., LTD."Report for Q3 2026

· Issued by Shanghai OPM Biosciences Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 688293 · · 21 pages · Chinese

Summary by 6ix AI

The report highlights a notable increase in revenue compared to the previous year, alongside a decrease in net profit attributable to shareholders due to acquisition-related accounting impacts. It also discusses the integration of a newly acquired subsidiary and its effects on the company's financial performance and operational capabilities. The filing includes a comprehensive overview of shareholder information and risk factors associated with goodwill impairment and financial liabilities.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Shanghai OPM Biosciences Co., Ltd. on 6ix

Earlier from Shanghai OPM Biosciences

Later from Shanghai OPM Biosciences

All Shanghai OPM Biosciences news releases